PRIMARY STUDY

A Review of Cannabis in Chronic Kidney Disease Symptom Management

Key Findings:  Medical marijuana has emerged as an attractive therapeutic option for CKD, but continues to be used for a variety of unsubstantiated indications with minimal guidance on known risks, particularly with respect to the altered physiological state of patients with CKD. At this time, the supportive evidence for using nonsynthetic cannabinoids for symptom management is limited to the treatment of chronic neuropathic pain, with promising potential when used topically for the treatment of uremic pruritus.

Type of Study:  Meta-analysis

Study Result:  Positive

Study Location(s):  Canada

Year of Pub:  2019


Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Pharma THC:CBD

Phytocannabinoid Source:  Not Applicable